NVO

Novo Nordisk A/S (NVO)

Last Price$78.7(5.3%)
Market Cap$350.5B
$39.3B
+26.2% YoY
$13.8B
+25.8% YoY
($2,672.6M)
Net Debt to FCF - (0.3x)
$9,793.1M
24.9% margin

NVO Income Statement

NVO Income Statement Overview

Crunching data... Almost there!

NVO Income statement key metrics

Annual
Quarterly
LTM

Revenue

$33.7B +31.3% YoY
Dec'14Dec'16Dec'18Dec'20Dec'22$15.8B$16.6B$17.7B$19.4B$25.0B
Revenue
Revenue growth

Operating Income

$14.9B +37.1% YoY
Dec'14Dec'16Dec'18Dec'20Dec'22$6,142.8M$7,194.8M$7,480.9M$8,278.5M$10.6B
Operating Income
Operating margin

Net Income

$12.1B +50.7% YoY
Dec'14Dec'16Dec'18Dec'20Dec'22$4,716.1M$5,633.9M$6,116.1M$6,444.9M$7,853.6M
Net Income
Net Income margin

NVO Balance Sheet

NVO Balance Sheet Overview

Annual
Quarterly
LTM
Dec'14
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Assets
Liabilities
Total assets
$46.6B
Current assets ($20.7B, 44.4% of total)
$4,474.6M (9.6%)
$11.1B (23.9%)
Other current assets
$5,055.6M (10.9%)
Non-current assets ($25.9B, 55.6% of total)
$246.2M (0.5%)
$8,280.5M (17.8%)
Other non-current assets
$3,889.1M (8.4%)
Financial position
($477.2M)
$4,474.6M$3,997.4M
Cash & Short-term Investments
Total Debt

NVO Balance Sheet Metrics

Crunching data... Almost there!

NVO Cash Flow Statement

NVO Cash Flow Statement Overview

Crunching data... Almost there!

NVO Cash Flow Statement key metrics

Annual
Quarterly
LTM

Operating Cash Flow (OCF)

$15.8B +38.1% YoY
Dec'14Dec'16Dec'18Dec'20Dec'22$5,644.1M$7,177.2M$7,064.2M$7,945.8M$11.2B
OCF
OCF margin

Capital Expenditure (CAPEX)

($5,637.6M) +163.6% YoY
Dec'14Dec'16Dec'18Dec'20Dec'22($772.0M)($1,228.1M)($1,964.9M)($3,377.3M)($2,086.7M)
CAPEX
CAPEX as % of Revenue

Free Cash Flow (FCF)

$10.1B +9.2% YoY
Dec'14Dec'16Dec'18Dec'20Dec'22$4,872.1M$5,949.1M$5,099.3M$4,568.6M$9,071.3M
FCF
FCF margin

NVO Financials

Crunching data... Almost there!